The Role of The African Vaccine Regulatory Forum (AVAREF) in The Accelerated Clinical Evaluation of Ebola Vaccine Candidates During the Large West Africa Epidemic

Autor: Ahmed Bellah, Richard Mihigo Immunization, Who Headquarters, Family, Who Regional Office for Africa Regulatory Systems Strengthening, David Mukanga, Tieble Traore, Mike Ward, Bartholomew Dicky Akanmori

Publikováno v: Journal of Immunological Sciences. 2:75-79

In emergency situations, clinical trials of new vaccines and therapies in resource-constrained settings place an additional burden on the limited resources of low and middle-income countries. The clinical trials of vaccines against Ebola Virus Diseas

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e7cce7fa1bdc9db629f4bf83c984e49b
https://doi.org/10.29245/2578-3009/2018/si.1111

Inclusion of cryoprecipitate, pathogen-reduced, in the WHO model lists of essential medicines for adults and children: a call for action.

Autor: Epstein JS; McLean, Virginia, VA, United States of America., Maryuningsih Y; Blood and other Products of Human Origin Team, WHO Headquarters, Geneva, Switzerland., Faber JC; Association Luxembourgeoise des Hémophiles, Luxembourg City, Luxembourg., Smid WM; Sanquin Consulting Services, Amsterdam and Academic Institute IDTM, Groningen, the Netherlands., Burnouf T; Graduate Institute of Biomedical Materials and Tissue Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei, Taiwan.; International PhD Program in Biomedical Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei, Taiwan.

Publikováno v: Blood transfusion = Trasfusione del sangue [Blood Transfus] 2024 Nov; Vol. 22 (6), pp. 481-483. Date of Electronic Publication: 2024 Jan 31.

Implementing the WHO Indicators for Assessing Palliative Care Development in Three Countries: A Do-It-Yourself Approach.

Autor: Tripodoro VA; ATLANTES Global Observatory of Palliative Care (V.A.T., E.G., F.B., A.M., A.C.B., J.J.P., M.C.B., C.C.), Institute Culture and Society, University of Navarra, Pamplona, Navarra, Spain; IdiSNA (V.A.T., C.C.), Instituto de Investigación Sanitaria de Navarra, Pamplona, Navarra, Spain. Electronic address: vtripodoro@unav.es., Ray A; Department of Integrated Health Services at WHO headquarters (A.R.), Geneva, Switzerland., Garralda E; ATLANTES Global Observatory of Palliative Care (V.A.T., E.G., F.B., A.M., A.C.B., J.J.P., M.C.B., C.C.), Institute Culture and Society, University of Navarra, Pamplona, Navarra, Spain., Bastos F; ATLANTES Global Observatory of Palliative Care (V.A.T., E.G., F.B., A.M., A.C.B., J.J.P., M.C.B., C.C.), Institute Culture and Society, University of Navarra, Pamplona, Navarra, Spain., Montero Á; ATLANTES Global Observatory of Palliative Care (V.A.T., E.G., F.B., A.M., A.C.B., J.J.P., M.C.B., C.C.), Institute Culture and Society, University of Navarra, Pamplona, Navarra, Spain., Béjar AC; ATLANTES Global Observatory of Palliative Care (V.A.T., E.G., F.B., A.M., A.C.B., J.J.P., M.C.B., C.C.), Institute Culture and Society, University of Navarra, Pamplona, Navarra, Spain., Pons JJ; ATLANTES Global Observatory of Palliative Care (V.A.T., E.G., F.B., A.M., A.C.B., J.J.P., M.C.B., C.C.), Institute Culture and Society, University of Navarra, Pamplona, Navarra, Spain; Department of History (J.J.P.), History of Art and Geography, University of Navarra, Pamplona, Navarra, Spain., Bouësseau MC; ATLANTES Global Observatory of Palliative Care (V.A.T., E.G., F.B., A.M., A.C.B., J.J.P., M.C.B., C.C.), Institute Culture and Society, University of Navarra, Pamplona, Navarra, Spain; Department of Integrated Health Services (M.C.B.), Geneva, Switzerland., Centeno C; ATLANTES Global Observatory of Palliative Care (V.A.T., E.G., F.B., A.M., A.C.B., J.J.P., M.C.B., C.C.), Institute Culture and Society, University of Navarra, Pamplona, Navarra, Spain; IdiSNA (V.A.T., C.C.), Instituto de Investigación Sanitaria de Navarra, Pamplona, Navarra, Spain.

Publikováno v: Journal of pain and symptom management [J Pain Symptom Manage] 2024 Sep 24. Date of Electronic Publication: 2024 Sep 24.

Status of HPV disease and vaccination programmes in LMICs: Introduction to special issue.

Autor: Borda H; Johns Hopkins Bloomberg School of Public Health, International Vaccine Access Center, 415 N Washington Street 5th Floor, Baltimore, MD 21231, United States. Electronic address: hshepar1@alumni.jh.edu., Bloem P; World Health Organization, WHO Headquarters, Avenue Appia 20, 1211 Geneva 27, Switzerland. Electronic address: bloemp@who.int., Akaba H; World Health Organization, WHO Headquarters, Avenue Appia 20, 1211 Geneva 27, Switzerland. Electronic address: akabah@who.int., Guillaume D; Johns Hopkins Bloomberg School of Public Health, International Vaccine Access Center, 415 N Washington Street 5th Floor, Baltimore, MD 21231, United States. Electronic address: dguilla2@jhmi.edu., Willens V; Johns Hopkins Bloomberg School of Public Health, International Vaccine Access Center, 415 N Washington Street 5th Floor, Baltimore, MD 21231, United States. Electronic address: vwillen1@jhu.edu., Jurgensmeyer M; Johns Hopkins Bloomberg School of Public Health, International Vaccine Access Center, 415 N Washington Street 5th Floor, Baltimore, MD 21231, United States. Electronic address: mjurgen4@jhu.edu., Muralidharan K; Johns Hopkins Bloomberg School of Public Health, International Vaccine Access Center, 415 N Washington Street 5th Floor, Baltimore, MD 21231, United States. Electronic address: kmuralidharan@jhu.edu., Limaye R; Johns Hopkins Bloomberg School of Public Health, International Vaccine Access Center, 415 N Washington Street 5th Floor, Baltimore, MD 21231, United States. Electronic address: rlimaye@jhu.edu.

Publikováno v: Vaccine [Vaccine] 2024 Jul 11; Vol. 42 Suppl 2, pp. S1-S8. Date of Electronic Publication: 2024 Nov 07.

Standardised protocol for a prospective international multicentre clinical-based evaluation of point-of-care tests for the screening of genital and extragenital chlamydial and gonococcal infections in men who have sex with men and for the screening of genital chlamydial, gonococcal and Trichomonas vaginalis infections in at risk women.

Autor: Cordioli M; WHO Collaborating Centre for Sexual Health and Vulnerable Populations - Epidemiology Unit - Division of Infectious Diseases, Department of Medicine, Verona University Hospital, Verona, Italy maddalena.cordioli@univr.it.; Infectious Division of Infectious Diseases, Department of Medicine, Verona University Hospital, Verona, Italy., Gios L; WHO Collaborating Centre for Sexual Health and Vulnerable Populations - Epidemiology Unit - Division of Infectious Diseases, Department of Medicine, Verona University Hospital, Verona, Italy.; Infectious Division of Infectious Diseases, Department of Medicine, Verona University Hospital, Verona, Italy., Mirandola M; WHO Collaborating Centre for Sexual Health and Vulnerable Populations - Epidemiology Unit - Division of Infectious Diseases, Department of Medicine, Verona University Hospital, Verona, Italy.; Infectious Division of Infectious Diseases, Department of Medicine, Verona University Hospital, Verona, Italy., Zorzi A; WHO Collaborating Centre for Sexual Health and Vulnerable Populations - Epidemiology Unit - Division of Infectious Diseases, Department of Medicine, Verona University Hospital, Verona, Italy.; Virology and Microbiology Unit, Department of Molecular Medicine, Padua University Hospital, Padua, Italy., Barbara C; Pathology Department, Mater Dei Hospital, Msida, Malta, Malta., Padovese V; Genitourinary Clinic, Department of Dermatology and Venereology, Mater Dei Hospital, Msida, Malta, L-Imsida, Malta, Malta., Hancali A; Ministry of Health, National Institute of Hygiene, Rabat, Morocco., Oumzi H; National Institute of Hygiene, Ministry of Health, Rabat, Morocco., Kularatne R; National Institute for Communicable Diseases, Johannesburg, South Africa., Jiang TT; Institute of Dermatology/Hospital for Skin Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing, China., Caceres CF; Unit of Health, Sexuality and Human Development, Universidad Peruana Cayetano Heredia, Lima, Peru., Vargas S; Laboratory of Sexual Health, Center for Interdisciplinary Research on Sexuality, AIDS and Society, Universidad Peruana Cayetano Heredia, Lima, Peru., Alvarez CS; Sida y Sociedad ONG (SISO), Escuintla, Guatemala., Camey E; Sida y Sociedad ONG (SISO), Escuintla, Guatemala., Peeling RW; Clinical Research Department, London School of Hygiene & Tropical Medicine, London, UK.; Medical Microbiology Department, University of Manitoba, Winnipeg, Manitoba, Canada., Unemo M; WHO Collaborating Centre for Gonorrhoea and Other STIs, Department of Laboratory Medicine, Örebro University, Örebro, Sweden.; Institute for Global Health, University College London (UCL), London, UK., Ballard R; Consultant to WHO Headquarters - Geneva, The Villages, Florida, USA., Blondeel K; Department of Reproductive Health and Research, World Health Organization, Geneva, Switzerland.; Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium., Kiarie J; Department of Reproductive Health and Research, World Health Organization, Geneva, Switzerland., Thwin SS; Department of Sexual and Reproductive Health and Research, World Health Organization, Geneva, Switzerland., Toskin I; Department of Reproductive Health and Research, World Health Organization, Geneva, Switzerland.

Publikováno v: BMJ open [BMJ Open] 2024 Jun 16; Vol. 14 (6), pp. e073565. Date of Electronic Publication: 2024 Jun 16.